Lipitor gives Ranbaxy heartache News of the conclusion inwards the conclusion of the Court of Appeal for England in addition to Wales inwards Ranbaxy UK Ltd v Warner-Lambert; Arrow Generics [2006] EWCA Civ 876 on 28 June has been trickling through the system, but the conclusion of Lords Justices Chadwick, Jacob in addition to Neuberger has non nonetheless been BAILII'd . constitute the summary on subscription-only service Lawtel quite helpful though. Warner Lambert was the possessor of ii patents (633 in addition to 281) for atorvastatin, a cholesterol synthesis inhibitor (better known every bit LIPITOR). Patent 633 covered ii structural formulae (I in addition to X) for an enantiomer. According to Ranbaxy it was mutual inwards organic chemical scientific discipline to purpose the structural formula of a unmarried enantiomer to announce the racemate (basically the 'left-handed' form) or 50/50 mixture of ii enantiomers of a chiral molecule. Since the racemate was to endure ...